About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Bioequivalence Study Of Verapamil

Bioequivalence Study Of Verapamil

NCT00668967·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Pfizer

Age

18–55

Sex

ALL

Healthy volunteers

Accepted

You may be eligible if

Healthy male and/or female subjects
Mass Index (BMI) of approximately 18 to 30 kg/m2

You may not be if

Any condition possibly affecting drug absorption
A positive urine drug screen

The record

StatusCompleted

PhasePhase 1

Taking part79

StartedFeb 2008

UpdatedJul 8, 2009

Conditions

Healthy Volunteers

Where1

Pfizer Investigational Site
New Haven, Connecticut, United States